Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population-Reference-Cited by-同舟云学术

Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population

Published:2021-12 Issue:6 Volume:75 Page:1292-1300
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Nielsen Mette Juul^ORCID,Leeming Diana Julie^ORCID,Goodman Zachary,Friedman Scott^ORCID,Frederiksen Peder,Rasmussen Daniel Guldager Kring^ORCID,Vig Pamela,Seyedkazemi Star,Fischer Laurent,Torstenson Richard,Karsdal Morten Asser,Lefebvre Eric,Sanyal Arun J.,Ratziu Vlad

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology,2019

2. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue;Daniels;Biomed Pharmacother,2019

3. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;J Hepatol,2016

4. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J Hepatol,2020

5. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis;Karsdal;Am J Physiol Gastrointest Liver Physiol,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis;New England Journal of Medicine;2024-07-25

2. Associations of exposure to bisphenol-A or parabens with markers of liver injury/function among US adults in NHANES 2011–2016;Journal of Exposure Science & Environmental Epidemiology;2024-07-17

3. Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD;Journal of Internal Medicine;2024-07-03

4. Aramchol improves hepatic fibrosis in metabolic dysfunction–associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology;Hepatology;2024-06-25

5. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD;Current Obesity Reports;2024-05-29